Top KKR partner Alisa Wood recalled being turned down by the firm's CEO, Henry Kravis, in 2003. See the rejection letter ...

LONDON (Reuters) -British scientific instruments maker Spectris has agreed to a sweetened offer from U.S. private equity firm ...

The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its ...

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...

Get income with KKR's Series D Preferred Shares offering a 5.5% yield, solid equity backing, tax benefits, and 2028 mandatory ...

The firm, which beat earnings estimates Thursday, is leaning on credit strategies as dealmaking slowly recovers.

British scientific instruments maker Spectris SXS.L has agreed to private equity firm Advent's sweetened takeover offer worth ...

The New York investment firm posted a profit of $472.4 million, compared with $667.9 million a year earlier.

KKR’s investment will be used to recapitalize DXC; DentalXChange will continue to operate under its current leadership team, led by CEO Paul Kaiser; KKR has made an investment i ...

KKR ups its bid for Spectris to £4.2 billion, overtaking Advent in a fierce takeover race for the UK scientific instruments ...

US private equity group’s offer nudges out rival bidder once again in race to acquire UK scientific instruments maker ...

KKR & Co. ( NYSE: KKR) announced on Monday the commencement of an offering of senior notes. Shares were +0.50% pre-market to $143.26. The terms of the sale were not disclosed. Net proceeds are ...